Filing Overview
Clover Health Investments, Corp. filed a Form 8-K dated June 5, 2023, under Item 5.02 regarding a change in executive personnel. The company’s Class A common stock trades on Nasdaq under the symbol CLOV.
Business Context and Reporting Period
The filing reports that Joseph Martin notified the company of his resignation as General Counsel and Corporate Secretary, effective June 16, 2023. He stated that he is leaving to pursue a new role at another public company.
Financial and Operating Metrics
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, operating performance, or other financial metrics.
Material Changes Versus Prior Period
The material change disclosed is the planned departure of the General Counsel and Corporate Secretary. The filing does not describe a successor, transition arrangements, severance, or any financial impact from the resignation.
Guidance, Outlook, Risks, and Unusual Items
Management characterized Mr. Martin’s departure positively and did not disclose changes to business guidance or outlook. No new contingencies, litigation matters, unusual items, or specific risks were reported in the filing.
Investor Verification Items
- Verify the effective departure date of June 16, 2023.
- Check subsequent filings for the appointment of a new General Counsel or Corporate Secretary.
- Review subsequent disclosures for any compensation, severance, transition, or governance implications.
- Confirm whether later filings identify any effect on the company’s operations, compliance, or reporting processes.